Andreas H M De Vries

Title: Andreas H M De Vries: Innovator in Pharmaceutical Chemistry

Introduction

Andreas H M De Vries is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antimicrobial compounds and novel catalyst systems. With a total of 2 patents, his work has implications for therapeutic agents and asymmetric catalysis.

Latest Patents

His latest patents include "Boronic acid derivatives and synthesis thereof," which discloses antimicrobial compound compositions and their pharmaceutical applications. This patent highlights the use of boronic acid derivatives as therapeutic agents, specifically as β-lactamase inhibitors (BLIs). Another significant patent is the "Process for transition metal-catalyzed asymmetric hydrogenation of acrylic acid derivatives," which details a method for hydrogenating acrylic acid derivatives using a novel catalyst system involving transition metals and chiral ligands.

Career Highlights

Throughout his career, Andreas has worked with reputable companies such as Qpex Biopharma, Inc. and DSM Fine Chemicals Austria Nfg GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and catalysis.

Collaborations

Andreas has collaborated with esteemed colleagues, including Laurent Lefort and Scott J Hecker. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Andreas H M De Vries stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative patents and collaborations reflect his commitment to advancing therapeutic solutions and catalysis.